|Year : 2021 | Volume
| Issue : 4 | Page : 906-911
Incidence of melanoma and nonmelanoma skin cancers in Indian and the global regions
Satyanarayana Labani1, Smita Asthana1, Kushal Rathore1, Kabir Sardana2
1 Division of Epidemiology and Biostatistics, National Institute of Cancer Prevention and Research, Indian Council of Medical Research, Noida, Uttar Pradesh, India
2 Department of Dermatology, Dr. RML Hospital and PGIMER, New Delhi, India
|Date of Submission||23-Sep-2019|
|Date of Acceptance||21-Jan-2020|
|Date of Web Publication||13-Oct-2020|
Division of Epidemiology and Biostatistics, National Institute of Cancer Prevention and Research, Indian Council of Medical Research, I-7, Sector-39, Noida, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
Background: Incidence of common types of skin cancers in India is not reported and its comparison with global load would be helpful statistics.
Aim: The aim of this study is to summarize and report recent skin cancer incidence in India and to compare it with the incidence globally.
Materials and Methods: Age-specific rates and age-adjusted rates (AARs) of the incidence of skin cancer for all ages (0–75 years) were collected from India and the world, respectively, from the National Cancer Registry Programme and GLOBOCAN 2018.
Results: The AAR per 100,000 of melanoma of the skin was highest in the North region of India for both males and females with 1.62 and with 1.21, respectively. The incidence of nonmelanoma of the skin or other skin cancers for males was highest in the East region with 6.2 and for females in Northeast with 3.49. Among nonmelanoma, northeast region showed the maximum incidence for both male (75.6) and female (43.6) sexes. Globally, AAR of melanoma of skin for males was highest in the Western Pacific region with 36.9 and for the females; AAR was highest in the European region with 31.7. The incidence of nonmelanoma of the skin or other skin cancers for males was highest in the Western pacific region with 225.4 and 68.6 for females.
Conclusion: Summary of the incidence rates of melanoma and nonmelanoma skin cancers which shows that though there are regional variations of incidence in India is lower than that of in the West.
Keywords: Incidence, melanoma, nonmelanoma, skin cancer
|How to cite this article:|
Labani S, Asthana S, Rathore K, Sardana K. Incidence of melanoma and nonmelanoma skin cancers in Indian and the global regions. J Can Res Ther 2021;17:906-11
| > Introduction|| |
Skin cancers are commonly divided into two broad heads, nonmelanoma skin cancers (NMSCs) which consist of basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) and melanomas. The latter is not as common as the NMSCs in India, but their severity is far more than that of nonmelanomas. NMSCs have a high incidence in European populations. Of the NMSCs, SCC is more common than BCC among dark-skinned individuals. Radiotherapy commonly induces BCC while human papillomavirus predisposes to SCC MSCs. Melanomas can also be cured in its early stages but if left untreated, it is likely to spread to other parts of the body, where it can be very difficult to treat.
A total of 18.1 million new cases and 9.6 million deaths from skin cancer were estimated globally in 2018. Global burden of disease study 2015 included data on melanoma incidence, mortality, and disability life years (DALY) and the assessment of global, regional, and national estimates. The worldwide incidence of NMSC was systematically reviewed using 75 studies, it was observed that most of the studies focused on white populations in Europe, the USA, and Australia, but there were limited studies in Africa. The review revealed that NMSC is a growing problem and stressed the need for studies on the prevention of the disease. A recent study on the epidemiology of skin cancer  stated that in Europe, the incidence would increase to 40–50/100,000 inhabitants per year in the next decade. Studies from India report clinicopathological evaluation  and also focus on the current scenarios of NMSCs, but a systematic pan-India data analysis has not been published.
Cancer statistics are available from several cancer registries in various countries globally. A cancer registry is an organization for systematic collection, storage, analysis, interpretation, and reporting of data on subjects with cancer. These provide population-based incidence and mortality rates from population-based cancer registries (PBCRs). Knowledge of the burden of cancer helps in etiologic studies and the effectiveness of the activities that have been undertaken to control cancer. Incidence data on skin cancers from India and its global comparison are perhaps not reported. Although the full cancer statistics is available on Globocan and in different cancer registry sites, a summary of important cancers such as melanoma and nonmelanoma might help researchers and policy-makers as a ready record to understand the magnitude of this cancer. Thus, we aimed to summarize and report incidence of melanoma of the skin and other skin cancers using data from the National Cancer Registry Programme (NCRP) India and GLOBOCAN.
| > Materials and Methods|| |
Indian data on the incidence of skin cancers for the present study were obtained from the published consolidated reports of 29 PBCRs (2012–2014) NCRP) of the Indian Council of Medical Research (ICMR). This data from NCRP were available on two broad cancer categories such as melanoma of the skin and other skin cancers. As per the International Classification of Disease version 9 codes, Melanoma of the skin was C43 and other skin cancer was C44. Age-specific rates (ASRs) of incidence of skin cancer up to the age of 75 years and above and age-adjusted rates (AAR) of incidence for melanoma of the skin and other skin cancers in both the sexes in each of the 29 registries were obtained and were presented region-wise. The PBCRs in various parts across the country were divided into six regions for the present study which are as follows: North: Delhi, Patiala, South: Bangalore, Chennai, Kollam, Thiruvananthapuram, Central: Bhopal, East: Kolkata, Northeast: Cachar district, Kamrup urban, Manipur, Mizoram, Nagaland, Meghalaya, Sikkim and Tripura, West: Mumbai, Nagpur, Pune, Ahmedabad and Barshi extended. The data of Indian registries are available for public use on NCRP-ICMR website. The data of cancer incidence from sites other than melanoma were termed as nonmelanoma of skin category.
Age-specific rates (ASRs) and AARs of the incidence of melanoma skin cancer and other skin sites in world for both the sexes and all ages (0–75 years) were collected from the report of the International Agency for Research on Cancer (IARC) by GLOBOCAN 2018 in 185 International Association of Cancer Registries).,, The world regions were divided into six regions for the present study which are as follows: African Region, American Region, South-East Asia Region, European Region, Eastern Mediterranean Region, Western Pacific Region. The global data of world regions are available for public use on GCO. IARC website.,
Cumulative risk (s) computed by NCRP  and GLOBOCAN  were based on the following formulae: Cumulative risk = 100 × (1 − exp [ −cumulative rate/100]) where, cumulative rate = (5× Σ [ASR] ×100)/100,000 and ASR is age-specific incidence rate(s). The multiplication factor five in the above formula of cumulative rate indicates the 5-year age intervals in ASRs. We computed another indicator, one in a number of persons likely to develop skin cancer in the lifetime of 0–75 years, for each skin cancer (melanoma and nonmelanoma) in each registry by using a formula 100/cumulative risk. Data on indicators, namely incidence rates, AARs and one in a number of persons develop cancer were summarized for both the sexes in each of the cancer registries and presented region-wise in the form of ranges.
| > Results|| |
The AARs for India and the world in the age of 0–75 years are presented region-wise for melanoma and other skin cancers) [Table 1]. In India, AAR incidence of melanoma of the skin was highest in the North region with 1.62 for males and 1.21 for females. Incidence of NMS for males was highest in the East region with 6.2 and in females in the Northeast region (3.49). Percent of melanoma of the skin out of all cancers for both males and females was highest in North with 1.06 and 0.8, respectively. For males and females, NMSC is highest in the Northeast region with 5.14 and 3.98, respectively [Table 1].
|Table 1: Age-adjusted rates of incidence of skin cancer among males and females in India|
Click here to view
Globally, melanoma incidence (AAR) was 36.9 in the Western pacific region for males and for females; it was 31.7 in the European region. The incidence of NMSC was highest in the Western Pacific region both for males (225.4) and females (68.6) [Table 2]. The percent of melanoma of the skin out of all cancers for both males and females was highest in the European region with 48.3 and 53.5, respectively. Percent of nonmelanoma out of all cancers was highest in the American regions with 43.4 for males and 41.5 for females [Table 2].
|Table 2: Age-adjusted rates rate of incidence of skin cancer among males and females in the world|
Click here to view
| > Discussion|| |
The present study focuses on the incidence rates of melanoma and nonmelanoma skin cancers in India and worldwide. Moreover, the study also identifies the regions of India and the world with the highest cases of melanoma and nonmelanoma skin cancers. In India, among males, the incidence of both melanoma and nonmelanoma skin cancers was highest in Northeast region. Further, in the Northeast region, the incidence of melanoma was highest in Nagaland and the incidence of nonmelanoma was highest in Pasighat. Among females, the incidence of melanoma was highest in northern region (Delhi) and the incidence of other skin cancers was highest in northeast region (Pasighat). According to the AAR, the incidence of melanoma skin cancer for both males and females was highest in northern region, 1.62 and 1.21, respectively. The incidence of nonmelanoma skin cancer for males was highest in Eastern region (6.2) and for females the incidence was highest in Northeast region.
Risk factors for NMSC are environmental, chemical exposures, chronic cutaneous inflammation, immunosuppression, fair phenotype, and any previous history of skin cancer. Among environmental risk factor important ones are UV radiation, indoor tanning, ionizing radiation, and psoralen UVA (PUVA) therapy. Arsenic and polycyclic aromatic hydrocarbons are the important chemical risk factors. Arsenic and UV exposures are supposed to be the most important for the Indian population. Risk factors for melanoma are the causes of melanoma greater than five sunburns, indoor tanning, PUVA phototherapy, fair phenotype, Parkinson's disease, immunosuppression, and any personal and/or family history of melanoma. The most likely cause in the Indian population for skin cancer are the combinations of PUVA and fair phenotype.
In the regions of the world, the incidence of melanoma and nonmelanoma skin cancers was highest in western pacific region. Further, in the Western Pacific region, the incidence of both skin cancers was highest in Australia and for females, the cases of melanoma were highest in New Zealand and the cases of nonmelanoma were highest in Australia. According to the AAR the incidence of melanoma skin cancers for males was highest in the Western Pacific region with 36.9 and for females, this incidence was highest in the European region with 31.7. The incidence of nonmelanoma skin cancer for both males and females was highest in Western Pacific regions.
The global burden of melanoma was reported from the burden of disease studies of 2015. It observed that the greatest melanoma incidence was in the five world regions such as Australia, North America, Eastern Europe, Western Europe, and Central Europe. DALY and mortality were greater in males than in females, in those with age >75 years. A study reported early detection strategies for melanoma and other skin cancer. It was reported that a 5-year melanoma survival rate in the USA rose from 49% to 82% in the year 1990. In the early 1990s, the incidence of cutaneous melanomas in whites was mounting faster than any other cancer. A study from Denmark reported the increased incidence of melanoma in situ in Denmark from 1997 to 2011. During this period, melanoma in situ incidence increased from 2.6 to 8.1 and 1.4 to 4.6 in females and males, respectively. The incidence rates of both melanoma and nonmelanoma skin cancers are increasing globally, but the mortality rates are either declining or stable. Various authors suggested based on epidemiology from migration studies and observational, high susceptibility to melanoma initiation might be due to excessive exposure to ultraviolet (UV) radiation. Actually, UV radiation has both harmful and beneficial effects on human skin. Ionization due to UV-C may act as strong mutagen causing cancer. Other mechanism such as free radical injury due to UV radiation might also be a cause of skin cancer. In response to UV light apoptosis of keratinocytes is responsible for skin protection against cancer. This mechanism in addition to other defense mechanism such as dissipation of UV radiation by activated melanin pigment plays a preventive role in skin cancer. There is a need to prevent harmful effects of increased harmful UV radiations. Another study evaluated the effect of regular sunscreen to prevent cutaneous melanoma. The study found the reduction in invasive melanoma (hazard ratio [HR], 0.27; 91% confidence interval [CI], 0.08–0.97) compared to that of preinvasive melanoma (HR 0.73; 95% CI, 0.29–1.81) and concluded that melanoma is preventable by using sunscreen in adults. National Cancer Institute's Surveillance, Epidemiology, and End Results data revealed the United States' striking disparity of 55% difference in melanoma survival between young men and women of ages of 15–39 years. A study from India introduced a precise melanoma segmentation technique based on the Gradient and Feature Adaptive Contour (GRAC) model to detect melanoma skin cancer in the earliest stage and diagnosis of dermoscopic images. Another study  applied an efficient melanoma diagnosis approach using integrated HMF multi-atlas map-based segmentation.
A model-based study on the prevalence of nonmelanoma skin cancer indicated that its prevalence is about five times higher than that of breast or prostate cancer and >31 years' prevalence of all other cancers combined and emphasized the need for population-based incidence and burden data for basal cell carcinoma and SCC. A recent systematic review also reported worldwide incidence of nonmelanoma skin cancers. The review observed that the studies were focused mostly on white population in Europe, USA, and Australia and the data for African region was limited. The basal cell carcinoma incidence rates in the UK were increasing at a greater rate than the rest of the Europe and reviews suggested the requirement of prevention studies on nonmelanoma skin cancers worldwide. Studies also reported that daily sunscreen application and beta-carotene supplementation is helpful for the prevention of basal cell and SCC of the skin. While beta-carotene supplementation did not reveal any beneficial or harmful effects on either type of skin cancers, sunscreen application was useful for the prevention of cutaneous SCC, but not for basal cell carcinoma.
The skin cancer incidence in India is low in proportion (0.5-–4.8 among females and 0.04–6.2 among males) to all other cancers [Table 1] and [Table 2] in comparison with regions of the globe (8.1–79.6 in females and 5.1–79.1 in males). A review  suspected that genetic susceptibility played an important role in arsenic susceptibility. Exposure to ultraviolet B (UVB) radiation and higher levels of arsenic in drinking water has been reported to be associated with skin cancers. No statistically correlation was found between number of lesions and arsenic content in the hairs and nails of the patients. In India, the regional variations can be explained, by certain established facts. The link of melanoma and UV light is known and this has a connection with the skin type. The Type I and II skin in the North East in conjunction with the high UV flux in that area can explain the higher incidence of NMSC and melanoma. In the East along the Ganges and parts of North India, there is a belt prone to arsenicosis which is a potential carcinogen. The increased melanoma in Delhi is inexplicable, but is probably a referral bias. The marked difference in the incidence with the Western data is a heartening feature and the higher incidence in the West is explained by the skin type of the Western Skin (type I) and the high ambient UV flux., Male preponderance for skin cancers could possibly be due to the higher UV light exposure in males due to outdoor occupational activity.
In India, at present, there are 29 PBCRs and the coverage of around 11% of the total population of India has been done. Although these registries cover various parts of our country, they do not efficiently represent various regions which are far distant from the center of location of PBCRs. In the absence of any source of data on magnitude of skin cancer, data from PBCRs are the only source which provides authentic data on the incidence and mortality of this cancer. The registries reported data on skin cancer only in two broad categories such as melanoma of skin and other skin cancers and this becomes a limitation of our study in the absence of incidence in subcategories of other skin cancers. Another limitation is that a large number of skin cancers are not registered by dermatologists in skin cancer registries.
| > Conclusion|| |
The proportion of skin cancers is high in some particular regions of India as well as of the world. Nonmelanoma skin cancers have high incidence rate globally. Thus, effective interventions are needed to reduce the incidence of skin cancer to reduce the global burden of disease.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| > References|| |
Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649-62.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M, et al
. The global burden of melanoma: Results from the Global Burden of Disease Study 2015. Br J Dermatol 2017;177:134-40.
Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166:1069-80.
Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol 2014;810:120-40.
Adinarayan M, Krishnamurthy SP. Clinicopathological evaluation of nonmelanoma skin cancer. Indian J Dermatol 2011;56:670-2.
] [Full text]
Panda S. Nonmelanoma skin cancer in India: Current scenario. Indian J Dermatol 2010;55:373-8.
] [Full text]
Noell C, Aleissa S, Nguyen B. Skin cancer: At-risk populations and prevention. In: Hanlon A, editors. A Practical Guide to Skin Cancer. Cham: Springer; 2018. p. 1-20.
Toender A, Kjær SK, Jensen A. Increased incidence of melanoma in situ
in Denmark from 1997 to 2011: Results from a nationwide population-based study. Melanoma Res 2014;24:488-95.
Pfahlberg A, Kölmel KF, Gefeller O; Febim Study Group. Timing of excessive ultraviolet radiation and melanoma: Epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation- induced melanoma. Br J Dermatol 2001;144:471-5.
Mohania D, Chandel S, Kumar P, Verma V, Digvijay K, Tripathi D, et al
. Ultraviolet radiations: Skin defense-damage mechanism. Adv Exp Med Biol 2017;996:71-87.
Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: Randomized trial follow-up. J Clin Oncol 2011;29:257-63.
Fisher DE, Geller AC. Disproportionate burden of melanoma mortality in young U.S. men: The possible role of biology and behavior. JAMA Dermatol 2013;149:903-4.
Sreelatha T, Subramanyam MV, Prasad MN. Early detection of skin cancer using melanoma segmentation technique. J Med Syst 2019;43:190.
Roja Ramani D, Ranjani SS. An efficient melanoma diagnosis approach using integrated HMF multi-atlas map based segmentation. J Med Syst 2019;43:225.
Stern RS. Prevalence of a history of skin cancer in 2007: Results of an incidence-based model. Arch Dermatol 2010;146:279-82.
Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, et al
. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial. Lancet 1999;354:723-9.
Paul S, Majumdar S, Giri AK. Genetic susceptibility to arsenic-induced skin lesions and health effects: A review. Genes Environ 2015;37:23.
Lal ST, Banipal RP, Bhatti DJ, Yadav HP. Changing trends of skin cancer: A tertiary care hospital study in Malwa Region of Punjab. J Clin Diagn Res 2016;10:PC12-5.
Ghosh SK, Bandyopadhyay D, Bandyopadhyay SK, Debbarma K. Cutaneous malignant and premalignant conditions caused by chronic arsenicosis from contaminated ground water consumption: A profile of patients from eastern India. Skinmed 2013;11:211-6.
Bindal S, Singh CK. Predicting groundwater arsenic contamination: Regions at risk in highest populated state of India. Water Res 2019;159:65-76.
Roider EM, Fisher DE. Red hair, light skin, and UV-independent risk for melanoma development in humans. JAMA Dermatol 2016;152:751-3.
UV light accelerates melanoma metastasis. Cancer Discov 2014;4:625-6.
[Table 1], [Table 2]
|This article has been cited by|
||Dhoti cancer – A name forgotten!!!
| ||V.S Haritha, Shyamji Rawat |
| ||IP International Journal of Medical Paediatrics and Oncology. 2022; 8(2): 69 |
|[Pubmed] | [DOI]|
||BOX-BEHNKEN DESIGN APPROACH TO DEVELOP NANO-VESICULAR HERBAL GEL FOR THE MANAGEMENT OF SKIN CANCER IN EXPERIMENTAL ANIMAL MODEL
| ||TRINAYAN DEKA, MALAY K. DAS, SANJOY DAS, PUNAMJYOTI DAS, L. RONIBALA SINGHA |
| ||International Journal of Applied Pharmaceutics. 2022; : 148 |
|[Pubmed] | [DOI]|
||Design-of-Experiments (DoE)-Assisted Fabrication of Quercetin-Loaded Nanoemulgel and Its Evaluation against Human Skin Cancer Cell Lines
| ||Aman Chitkara, Bharti Mangla, Pankaj Kumar, Shamama Javed, Waquar Ahsan, Harvinder Popli |
| ||Pharmaceutics. 2022; 14(11): 2517 |
|[Pubmed] | [DOI]|
||Clinical profile and outcomes of malignant melanoma in patients from an Indian institute: A retrospective analysis
| ||Sorun Shishak, Abhenil Mittal, Harshal Aswar, Rambha Pandey, Kaushal Kalra, Aarushi Gupta, Adarsh Barwad, Ekta Dhamija, ShamimAhmed Shamim, Aditi Aggarwal, SoorejBalan Kaliyath, Sameer Rastogi |
| ||Cancer Research, Statistics, and Treatment. 2021; 4(4): 621 |
|[Pubmed] | [DOI]|
||Melanoma: Gaps in knowledge and treatment
| ||Anand Raja, ChandraKumar Krishnan |
| ||Cancer Research, Statistics, and Treatment. 2021; 4(4): 728 |
|[Pubmed] | [DOI]|
||The efficacy and safety of combined ipilimumab and nivolumab versus ipilimumab in patients with Stage III/IV unresectable melanoma: A systematic review and meta-analysis
| ||Yuqing Zhu, Hui Cheng, Minhong Zhong, Yijie Hu, Qiushuang Li, Xiangfu Gao, Shan Liu |
| ||Journal of Cancer Research and Therapeutics. 2021; 17(7): 1679 |
|[Pubmed] | [DOI]|
||Antiskin Cancer and Antioxidant Activities of Formulated Agar from Brown Seaweed Laminaria digitata (Hudson) in Dimethyl Benzanthracene-Induced Swiss Albino Mice
| ||Jeneesha George, A. Thabitha, N. Vignesh, V. Manigandan, R. Saravanan, Ghaji Daradkeh, M. Walid Qoronfleh, Antonio Caggiano |
| ||International Journal of Polymer Science. 2021; 2021: 1 |
|[Pubmed] | [DOI]|